Nanoscience unit signs sports licensing agreement for initial 1 5 mln pounds: related news

Nanoscience unit signs sports licensing agreement for initial 1.5 mln pounds

LONDON (Thomson Financial) - Nanoscience Inc., said its wholly owned Toumaz Technology Ltd. has signed a new licensing agreement for an initial 1.5 million pounds with a sports-focused business originating in the Far East to develop Toumaz's Sensium brand globally through the sports industry.

Nanoscience unit signs sports licensing agreement for initial 1.5 mln pounds

The summer box office often sizzles as the calendar turns to July. What movies have opened best on the Independence Day holiday weekend?

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich.--(BUSINESS WIRE)--Jul 4, 2008 - ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich.--(BUSINESS WIRE)--July 4, 2008--ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

NANOSCIENCE INC: Toumaz Signs Sensium Sports Licensing Agreement

Hier finden Sie Nachrichten zu Ihrem Suchbegriff - Sie können den Zeitraum angeben oder auch Suchbegriffe kombinierenErweiterte Suche |

ABL signs patent licensing agreement with Viralliance

ABL Patent Licensing Technologies, a subsidiary of Advanced Biological Laboratories, has entered into a patent licensing agreement with Viralliance.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich. - ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, roya

Alcon signs patent cross-licensing agreement with AMO

Alcon has entered into a patent cross-licensing agreement with Advanced Medical Optics relating to lubricious coatings for intraocular lens insertion devices and a specified one-piece IOL design.

Altair Nanotechnologies Ships Battery Packs to Phoenix MC, Inc.: Companies Sign New Principles of Agreement Letter

Altair Nanotechnologies Inc. (NASDAQ: ALTI), a leading provider of advanced nanomaterials technology for use in energy, life sciences and industrial applications, today announced that it has signed a new Principles of Agreement Letter with Phoenix Motorcars, Inc. Under the terms of the agreement, Altair will ship 47 battery packs purchased by Phoenix in 2007 to Phoenix for use exclusively in demonstration vehicles. In addition, Altair entered into a letter of agreement with Phoenix formally terminating the existing supply agreement and mutually releasing each other from any claims under such agreement.

Applied Nanoscience and Emergency Filtration Products Announce Definitive Merger Agreement

Applied Nanoscience, Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, and Emergency Filtration Products, Inc. (EFP) (PINKSHEETS: EMFP), the developer of the NanoMask™, today announced that they have entered into a definitive merger agreement under which ANI has agreed to acquire EFP by issuing approximately 36,586,287 shares of its common stock and 18,293,143 warrants for the purchase of additional shares of ANI in exchange for the approximately 47,514,658 shares of EFP that are currently outstanding. ANI currently has approximately 24,315,569 common shares outstanding. The merger agreement requires the approval of the shareholders of both ANI and EFP.

Applied Nanoscience and Emergency Filtration Products Announce Definitive Merger Agreement

Applied Nanoscience, Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, and Emergency Filtration Products, Inc. (EFP) (PINKSHEETS: EMFP), the developer of the NanoMask™, today announced that they have entered into a definitive merger agreement under which ANI has agreed to acquire EFP by issuing approximately 36,586,287 shares of its common stock and 18,293,143 warrants for the purchase of additional shares of ANI in exchange for the approximately 47,514,658 shares of EFP that are currently outstanding. ANI currently has approximately 24,315,569 common shares outstanding. The merger agreement requires the approval of the shareholders of both ANI and EFP.

Applied Nanoscience and Emergency Filtration Products Announce Definitive Merger Agreement

Applied Nanoscience, Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, and Emergency Filtration Products, Inc. (EFP) (PINKSHEETS: EMFP), the developer of the NanoMask(TM), today announced that they have entered into a definitive merger agreement under which ANI has agreed to acquire EFP by issuing approximately 36,586,287 shares of its common stock and 18,293,143 warrants for the purchase of additional shares of ANI in exchange for the approximately 47,514,658 shares of EFP that are currently outstanding. ANI currently has approximately 24,315,569 common shares outstanding. The merger agreement requires the approval of the shareholders of both ANI and EFP.

Applied Nanoscience and Emergency Filtration Products Announce Definitive Merger Agreement

Applied Nanoscience, Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, and Emergency Filtration Products, Inc. (EFP) (PINKSHEETS: EMFP), the developer of the NanoMask(tm), today announced that they have entered into a definitive merger agreement under which ANI has agreed to acquire EFP by issuing approximately 36,586,287 shares of its common stock and 18,293,143 warrants for the purchase of additional shares of ANI in exchange for the approximately 47,514,658 shares of EFP that are currently outstanding. ANI currently has approximately 24,315,569 common shares outstanding. The merger agreement requires the approval of the shareholders of both ANI and EFP.

Applied Nanoscience and Emergency Filtration Products Announce Definitive Merger Agreement

CARLSBAD, CA and LAS VEGAS, NV -- 07/14/08 -- Applied Nanoscience, Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, and Emergency Filtration Products, Inc. (EFP) (PINKSHEETS: EMFP), the developer of the NanoMask™, today announced that they have entered into a definitive merger agreement under which ANI has agreed to acquire EFP by issuing approximately 36,586,287 shares of its common stock and 18,293,143 warrants for the purchase of additional shares of ANI in exchange for the approximately 47,514,658 shares of EFP that are currently outstanding. ANI currently has approximately 24,315,569 common shares outstanding. The merger agreement requires the approval of the shareholders of both ANI and EFP.

Applied Nanoscience and Emergency Filtration Products Announce Definitive Merger Agreement

CARLSBAD, CA and LAS VEGAS, NV--(MARKET WIRE)--Jul 14, 2008 -- Applied Nanoscience, Inc. (ANI) (Other OTC:APNN.PK - News), a nanotechnology-based filtration development company, and Emergency Filtration Products, Inc. (EFP) (Other OTC:EMFP.PK - News), the developer of the NanoMask™, today announced that they have entered into a definitive merger agreement under which ANI has agreed to acquire EFP by issuing approximately 36,586,287 shares of its common stock and 18,293,143 warrants for the purchase of additional shares of ANI in exchange for the approximately 47,514,658 shares of EFP that are currently outstanding. ANI currently has approximately 24,315,569 common shares outstanding. The merger agreement requires the approval of the shareholders of both ANI and EFP.

DUSA Announces Patent Licensing Agreement

today announced that it has entered into a non-exclusive patent license agreement granting River's Edge Pharmaceuticals, LLC rights for a vitamin-mineral product (nicotinamide, zinc, copper and folic acid) in the prescription market. DUSA is taking this action in light of the entry of generic products in this market and DUSA's need to enforce its intellectual property rights while trying to avoid litigation. DUSA, which previously sold its patented product in this market, now plans to sell its product under the dietary supplement rules as a result of discussions with the Food and Drug Administration. The one-year agreement is subject to an extension under certain terms and conditions and does not include a trademark license. As part of the agreement, DUSA will receive a share of the net revenues River's Edge generates.

Nokia, Qualcomm Settle Long Term Patent Suit

July 25, 2008 (FinancialWire) Cell phone maker Nokia (NYSE: NOK) (Current Market Cap: US$104.29 Bil.) and chip maker Qualcomm (NASDAQ: QCOM) have settled a 2005 patent dispute and have agreed to drop all legal claims against each other. The agreement to stop claims in North America, Europe and Asia thrilled Qualcomm investors. The company's shares soared 20% percent to $53.60 while Nokia s shares added 2% on Thursday. The 15-year licensing deal gives Nokia rights to a wide portfolio of Qualcomm's patents. Nokia will pay Qualcomm an upfront sum and ongoing royalties, but the companies did not elaborate on the terms. A licensing agreement between the two companies expired in April 2007. The new pact covers a host of technologies that didn't exist or were in their infancies when the two companies signed their initial agreement in 1992 and re

Dusa signs patent licensing agreement with River's Edge

Dusa Pharmaceuticals has signed a non-exclusive patent license agreement granting River's Edge Pharmaceuticals rights for a vitamin-mineral product in the prescription market.

EA Sports games returning to PC in 2009

During the EA analyst conference call EA Sports head Peter Moore announced that EA Sports games would be making a return to the PC next year: "As many of you probably noticed, this year we cut back on our PC sports games, but only for a year," said EA Sports chief Peter Moore. "We were retooling these titles to take advantage of the online connectivity in a bigger and more meaningful way. Stay tuned for more on this."

Deca Sports Sees 700k Shipped Worldwide

Hudson Soft today announced that Deca Sports has shipped 700,000 units worldwide. The Wii title was released as Deca Sporta in Japan in March 2008, followed by a U.S. release in May as Deca Sports with a European release as Sports Island in June. Hudson noted that they are looking to develop titles that "follow in the footsteps of Deca Sports."

Search took 0.18 seconds.